comparemela.com

Latest Breaking News On - Aadi bioscience daily - Page 2 : comparemela.com

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Increases By 16.6%

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 1,100,000 shares, a growth of 16.6% from the March 31st total of 943,100 shares. Approximately 6.3% of the shares of the stock are short sold. Based […]

Neil-desai
Aadi-bioscience
Decheng-capital
Exchange-commission
Nasdaq
Aadi-bioscience-inc
Get-free-report
Chairman-neil-desai
Free-report
Aadi-bioscience-daily

Reviewing Aadi Bioscience (NASDAQ:AADI) and Statera Biopharma (NASDAQ:STAB)

Aadi Bioscience (NASDAQ:AADI – Get Free Report) and Statera Biopharma (NASDAQ:STAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Profitability This table compares Aadi Bioscience and […]

Colorado
United-states
Pacific-palisades
California
Fort-collins
Aadi-bioscience
Statera-biopharma
Cytocom-inc
Statera-biopharma-inc
Aadi-bioscience-inc
Get-free-report

Insider Selling: Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $41,053.32 in Stock

Insider Selling: Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $41,053.32 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Aadi-bioscience
Piper-sandler
Neil-desai
Aadi-bioscience-inc
Mercer-global-advisors-inc
Citigroup-inc
Nasdaq
Group-plc
Barclays-plc
Get-free-report
Chairman-neil-desai
Bioscience-stock-down

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 17,772 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 17,772 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $2.31, for a total value of $41,053.32. Following the completion of the sale, the chairman now directly owns 1,393,771 shares of […]

Neil-desai
Aadi-bioscience
Piper-sandler
Nasdaq
Tower-research-capital
Aadi-bioscience-company-profile
Schonfeld-strategic-advisors
Cubist-systematic-strategies
Jpmorgan-chase-co
Group-plc
Aadi-bioscience-inc
Get-free-report

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $73,080.00 in Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 42,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1.74, for a total value of $73,080.00. Following the completion of the sale, the chairman now owns 1,453,543 shares […]

Canada
Piper-sandler
Aadi-bioscience
Neil-desai
Barclays-plc
Group-plc
Nasdaq
Royal-bank
Aadi-bioscience-company-profile
Citigroup-inc
Aadi-bioscience-inc
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.